JPS5967208A - Disinfectant composition - Google Patents

Disinfectant composition

Info

Publication number
JPS5967208A
JPS5967208A JP17891982A JP17891982A JPS5967208A JP S5967208 A JPS5967208 A JP S5967208A JP 17891982 A JP17891982 A JP 17891982A JP 17891982 A JP17891982 A JP 17891982A JP S5967208 A JPS5967208 A JP S5967208A
Authority
JP
Japan
Prior art keywords
magnesium
acid
salt
water
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP17891982A
Other languages
Japanese (ja)
Other versions
JPS6141883B2 (en
Inventor
Tokuyuki Taniguchi
徳之 谷口
Masanori Oota
正典 太田
Hitoshi Sasahara
笹原 均
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nissan Chemical Corp
Original Assignee
Nissan Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Corp filed Critical Nissan Chemical Corp
Priority to JP17891982A priority Critical patent/JPS5967208A/en
Publication of JPS5967208A publication Critical patent/JPS5967208A/en
Publication of JPS6141883B2 publication Critical patent/JPS6141883B2/ja
Granted legal-status Critical Current

Links

Abstract

PURPOSE:The titled composition that is obtained by combining trichloroisocyanuric acid with a combination of isocyanuric acid and magnesium oxide or hydroxide or with magnesium or calcium isocyanurate, thus showing increased storage stability with H<+> concentration inhibited from increasing. CONSTITUTION:The titled composition is obtained by combining (A) 100pts.wt. of trichloroisocyanuric acid (TCCA) with (B) a combination of 100pts.wt. of isocyanuric acid and 5-80pts.wt. of MgO or Mg(OH)2 or (C) 5-100pts.wt. of magnesium or calcium cyanurate. The resultant composition can prevent the hydrogen ion concentration from increasing in a closed aqueous system by continuous use of TCCA and is kept stably for a long period of time in the preparation forms of dust, granules, pills or tablets, even under wet conditions. The magnesium or calcium salt of cyanuric acid is preferably di- or tri-salt.

Description

【発明の詳細な説明】 本発明は、使用時に水素イオン濃度上昇を防止し、また
、保存安定性が良い、トリクロロインシアヌール酸を含
む殺菌消毒剤組成物に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a disinfectant composition containing trichloroin cyanuric acid that prevents an increase in hydrogen ion concentration during use and has good storage stability.

従来、塩素化インシアヌール酸化合物は次亜塩素酸ナト
リウム液または高度さらし粉(主成分2次亜塩素酸カル
シウム)に比べ、水中に供給さnた活性塩素(残留塩素
)が安定であるために、少ない使用量で済み、また高度
さらし粉の如き、水酸化カルシウムや炭酸カルシウムを
含まず、完全溶解性であり、伺かつ強い殺菌力を有する
事から、広範囲の分野に便用さ扛ている。塩素化イソシ
アヌール酸化合物で2%にトリクロロインシアヌール酸
(以下TOOAと記す)ハ、排水、プール水、冷却水等
の殺菌消毒剤、またはスライムコントロール剤として、
粉状、顆粒状2錠剤等の剤形で大量に使用されている。
Conventionally, compared to sodium hypochlorite solution or highly bleached powder (main ingredient secondary calcium hypochlorite), chlorinated incyanuric acid compounds have a stable active chlorine (residual chlorine) supplied to water, so less It is useful in a wide range of fields because it requires only a small amount of use, does not contain calcium hydroxide or calcium carbonate like highly bleached powder, is completely soluble, and has strong sterilizing power. A chlorinated isocyanuric acid compound containing 2% trichloroincyanuric acid (hereinafter referred to as TOOA) can be used as a disinfectant for wastewater, pool water, cooling water, etc., or as a slime control agent.
It is used in large quantities in the form of powder, granules, two tablets, etc.

しかしながら、TOOAは閉鎖系の水系である貯留水2
例えば冷却水やプール水等の滞留水の殺菌消毒、及びス
ライムコントロール用として、4続又は間欠的に長時間
にわたって供給する場合、TOOAがその滞留水中で蓄
積し、水素イオン濃度が上昇する事がある。例えば、雨
水の如くアルカリ度の低い水ではこの傾向が顕著である
。また、冷却水の如く比較的汚染され易い水では残留塩
素の消費も早くなるが、それ故にTOOAの供給量も増
加するために水中の水素イオン濃度が上昇する。水素イ
オン濃度が上昇すると装置類の腐蝕が起り好捷しくない
However, TOOA is a closed water system with stored water 2
For example, when supplying stagnant water such as cooling water or pool water for sterilization and slime control, continuously or intermittently for a long period of time, TOOA may accumulate in the stagnant water and increase the hydrogen ion concentration. be. For example, this tendency is remarkable in water with low alkalinity such as rainwater. In addition, in water that is relatively easily contaminated, such as cooling water, residual chlorine is consumed quickly, and therefore the amount of TOOA supplied also increases, leading to an increase in the hydrogen ion concentration in the water. If the hydrogen ion concentration increases, equipment will be corroded, which is undesirable.

このため、貯留水の水素イオン濃度を上昇させないよう
に通常に、炭酸す) IJウムを定期的に散布する方法
で対処しているが、pHを測定し炭酸ナトリウム量を加
減し々がら供給する方法は煩雑である。
Therefore, in order to prevent the hydrogen ion concentration of the stored water from increasing, the solution is to regularly spray IJum (carbonate), but the pH is measured and the amount of sodium carbonate is gradually added. The method is complicated.

以上の閉鎖水系にT(EOAi連続使用する事による水
素イオン濃度の上昇防止に対する研究は、従来あまり行
なわれていないが、TcCAまタハジクロロイソシアヌ
ール酸の溶解性を改善すべく、これに対し、アルカリ性
物質を配合させた組成物が提案されている。
Research on preventing the increase in hydrogen ion concentration due to the continuous use of T(EOAi) in the above closed water system has not been conducted much, but in order to improve the solubility of TcCA or tahadichloroisocyanuric acid, Compositions containing alkaline substances have been proposed.

例えば日本国外(米国)で通常市販されているへの低溶
解性、即ち溶解速度が遅い事に対し。
For example, it has low solubility in products commonly sold outside Japan (the United States), that is, its dissolution rate is slow.

アルカリ性物質である炭酸ナトリウムを配合させ、溶解
速度全早め、水中の活性塩素の溶出を大ならしめる事を
意図している。しかしながら本錠剤は、水に湿った状態
で不安定であり、爆発性を有する塩化窒素ガスを発生す
る。即ち。
By incorporating sodium carbonate, an alkaline substance, it is intended to speed up the dissolution rate and increase the elution of active chlorine from the water. However, the tablets are unstable when wet with water and emit nitrogen chloride gas, which is explosive. That is.

取扱いに注意しなければならなく、保存時のめt″Lは
厳禁である。
It must be handled with care, and storage is strictly prohibited.

また、特公昭57−25004号公報はトリクロロイソ
シアヌール酸ヲ主成分とする錠剤でTCOAの溶解速度
を人々らしめる意図で、TCCAに対しシアヌール酸の
モノ、ジ、及びトリアルカリ金属塩(Na、K)’i配
合し、成形した錠剤が水中で崩壊し1分散せしめること
を提案しているが1本錠剤は保存時の安定性がやはり低
く、有効塩素の分解及び塩化窒素の発生も多い。壕だ、
水に湿った状態での安定性がか々り低く、好ましくない
In addition, Japanese Patent Publication No. 57-25004 discloses tablets containing trichloroisocyanuric acid as the main ingredient, with the intention of making the dissolution rate of TCOA more user-friendly. K)'i has been proposed, and the molded tablet disintegrates and disperses in water, but the stability of single tablets during storage is still low, and the decomposition of available chlorine and generation of nitrogen chloride are high. It's a trench.
It has very low stability when wet with water, which is not desirable.

以上の如(、TCOAは、そ扛自体反応性に富むためほ
とんどの物質に対して不安定である、本発明者らに閉鎖
水系でTOCAを連続使用する事による水素イオン濃度
の上昇を防止し。
As mentioned above, TCOA itself is highly reactive and is therefore unstable against most substances. .

かつ保存安定性が良い組成物を得る事を目的とし、上述
したTOOAの過敏な物性と塩化窒素生成のメカニズム
について鋭意研究の結果、驚くべきことに、アルカリ性
物質に対して極めて敏感なTOOAに、特定なアルカリ
性物質とインシアヌール酸を、またはTCCAに特定の
シアヌール酸塩を配合することで、極めて安定に配合で
きる事を見出し2本発明の完成に至った。
With the aim of obtaining a composition with good storage stability, we conducted extensive research into the sensitive physical properties of TOOA and the mechanism of nitrogen chloride production, and surprisingly, we found that TOOA, which is extremely sensitive to alkaline substances, The present inventors have discovered that by blending a specific alkaline substance with incyanuric acid, or by blending a specific cyanuric acid salt with TCCA, an extremely stable blend can be achieved, leading to the completion of the present invention.

即ち9本発明はTOOA100重量部に対して次のA)
又はB) A)インシアヌール酸5〜10町1部と酸化マグネシウ
ムまたは水酸化マグネシウム5〜80重量部 B)シアヌール酸のマグネシウム塩またはカルシウム塩
5〜100重量部 を配合する事を特徴とする殺菌消毒剤組成物である。
That is, 9 The present invention provides the following A) for 100 parts by weight of TOOA.
or B) A sterilization and disinfection characterized by blending A) 5 to 10 parts of incyanuric acid and 5 to 80 parts by weight of magnesium oxide or magnesium hydroxide.B) 5 to 100 parts by weight of magnesium salt or calcium salt of cyanuric acid. It is a drug composition.

ToCAに対して、酸化マグネシウムまたは水酸化マグ
ネシウムのみを配合する場合、TOOAの連続使用によ
る水素イオン濃度の上昇は防げられるが、保存時、特に
水に湿った状態(湿潤時)において安定性が悪く、塩化
窒素ガス等の発生が著るしい。(比較例参照) しかし、  TCCAK対し、酸化マグネシウムまたは
水酸化マグネシウムを単独で加えること々く、インシア
ヌール酸とを併用した。三成分の配合においては閉鎖水
系の水素イオン濃度の上昇を抑えるのみでなく、長時間
の保存及び湿潤時においても極めて安定な配合組成が得
られる。
When only magnesium oxide or magnesium hydroxide is added to ToCA, an increase in hydrogen ion concentration due to continuous use of TOOA can be prevented, but stability is poor during storage, especially when wet with water (humidity). , the generation of nitrogen chloride gas, etc. is significant. (See Comparative Example) However, magnesium oxide or magnesium hydroxide was often added alone to TCCAK, and incyanuric acid was also used in combination. The combination of three components not only suppresses the increase in hydrogen ion concentration in a closed aqueous system, but also provides an extremely stable composition even during long-term storage and humidity.

該配合組成げToCA100重量部に対【7.イソシア
ヌール酸を5〜100重量部好壕しくに10〜50重量
部と、酸化マグネシウム捷たげ水酸化マグネシウムを5
〜80重量部、好ましくは5〜50重量部を配合したも
のである。
[7. 5 to 100 parts by weight of isocyanuric acid, and 10 to 50 parts by weight of magnesium oxide, and 5 to 5 parts by weight of magnesium hydroxide.
~80 parts by weight, preferably 5 to 50 parts by weight.

もちろん、酸化マグネシウムと水酸化マグネシウムを同
時に配合してもかまわない。この配合の範囲外、即ちT
CcA100重量部に対し。
Of course, magnesium oxide and magnesium hydroxide may be combined at the same time. Outside the range of this formulation, i.e. T
Based on 100 parts by weight of CcA.

インシアヌール酸が5重量部以下もしくは、酸化マグネ
シウム、捷たは水酸化マグネシウムの配合が80重量部
以上においては、長期間の保存及び湿潤時の安定性が低
下し、また一方インシアヌール酸の配合が100重量部
以上もしくは酸化マグネシウム塩たげ水酸化マグネシウ
ムが5重句部以下では、TCOAによる閉鎖水系の水素
イオン濃度の上昇に抑制できない。
If incyanuric acid is less than 5 parts by weight or if magnesium oxide, slaked or magnesium hydroxide is mixed in more than 80 parts by weight, long-term storage and wet stability will decrease; If the amount of magnesium oxide salt and magnesium hydroxide is more than 5 parts by weight or less than 5 parts by weight, the increase in hydrogen ion concentration in the closed water system due to TCOA cannot be suppressed.

捷だ、好捷しい配合組成物として、TOOAに対してシ
アヌール酸のマグネシウム塩又はカルシウム塩を用いる
事によっても、TOOAによる閉鎖水系の水素イオン濃
度の上昇を抑制できる。
By using magnesium salt or calcium salt of cyanuric acid for TOOA as a convenient formulation, it is also possible to suppress the increase in hydrogen ion concentration in a closed water system caused by TOOA.

本発明で用いるシアヌール酸のマグネシウムt4又はカ
ルシウム塩は種々の方法で製造できるが、−例金示すと
シアヌール酸1モル当りと対広する酸化物または水酸化
物を05〜1.5モルを水性スラリーで常温上反応させ
て得らγLろものである。得られるシアヌール酸の塩は
、イソシアヌール酸と対応する酸化物または水酸化物の
モル比によってモノ塩CM(OtN+0s)Is)x、
 M u CaまたfiMgf示す〕、ジ塩CM* (
C+N+O+H)z 〕+ )り塩[M+ (C+ N
*O* L ]が得ら扛る。本発明で使用する場合、ジ
塩及びトリ塩が好ましい。TOOAにシアヌール酸のマ
グネシウム塩tたはシアヌール酸のカルシウム塩を配合
するfiU、TccA100重量部に対して、5〜10
0重量部であり、好才しくは1o〜6o重量部である。
The magnesium T4 or calcium salt of cyanuric acid used in the present invention can be produced by various methods. This is a γL product obtained by reacting a slurry at room temperature. The resulting salt of cyanuric acid can be converted into a monosalt CM(OtN+0s)Is)x, depending on the molar ratio of isocyanuric acid and the corresponding oxide or hydroxide.
M u Ca also fiMgf], di-salt CM* (
C+N+O+H)z 〕+ )ri salt [M+ (C+ N
*O*L] is obtained. Di- and tri-salts are preferred for use in the present invention. 5 to 10 parts by weight of fiU, TccA in which magnesium salt of cyanuric acid or calcium salt of cyanuric acid is blended with TOOA.
0 parts by weight, preferably 1 to 6 parts by weight.

シアヌール酸のカルシウム塩とシアヌール酸のマグネシ
ウム塩を同時に使用しても、もちろんかまわんい。この
配合の範囲外、即ちTcoAloo重量部に対し、シア
ヌール酸のマグネシウム塩又はカルシウム塩が5重量%
以下では。
Of course, it is okay to use the calcium salt of cyanuric acid and the magnesium salt of cyanuric acid at the same time. Outside the range of this formulation, i.e. 5% by weight of magnesium salt or calcium salt of cyanuric acid based on the weight part of TcoAloo.
Below.

TOOAにより水素イオン濃度が上昇し、捷た一方10
0重量部以上では、水に湿った時、即ち湿潤時の安定性
がなく、塩化窒素の発生が増加し好1しくない。前述し
たTOOAに対してイソシアヌール酸と酸化マグネシウ
ムまたハ水酸化マグネシウムの配合組成に、シ曵ヌール
酸のカルシウム塩又はマグネシウム塩を一緒に配合する
のはもちろんか貰わない。
TOOA increased the hydrogen ion concentration and reduced it.
If it is more than 0 part by weight, it is not stable when wetted with water, that is, when wet, and the generation of nitrogen chloride increases, which is undesirable. It goes without saying that a calcium salt or a magnesium salt of cyanuric acid should be added to the composition of isocyanuric acid and magnesium oxide or magnesium hydroxide for the TOOA described above.

以上の如く2本発明の配合組成物a、’rcaAを閉鎖
系の貯水槽において長期間、連続的に供給する場合にお
いても水素イオン濃度の上昇を抑えることができ、しか
も該配合組成物は安定に保存できる。捷だ該配合組成物
ニ、初末状。
As described above, even when the blended compositions a and 'rcaA of the present invention are continuously supplied for a long period of time in a closed water storage tank, the increase in hydrogen ion concentration can be suppressed, and the blended composition is stable. It can be saved to . The combination composition is in its initial state.

粒子状、丸状2錠剤等の任意の剤形でよく、造粒に必要
外結合剤、流動化剤、滑沢剤等の賦形剤及び崩壊剤等の
補助剤を加えてもよく、更に適宜に濃度調整の為に増量
剤を添加してもよい。
It may be in any desired dosage form, such as particulates or two round tablets, and additional excipients such as binders, fluidizers, and lubricants, and auxiliary agents such as disintegrants may be added to the granulation. A filler may be added to adjust the concentration as appropriate.

以下、実施例、比較例をもって本発明の詳細な説明する
が2本願の技術的範囲はこれに限定されるものでない。
The present invention will be described in detail below with reference to Examples and Comparative Examples, but the technical scope of the present application is not limited thereto.

実施例1 粒子径50〜350μ、含水ギ021%のTOOA、 
70重量部と2粒子径20〜200μ。
Example 1 TOOA with a particle size of 50 to 350μ and a water content of 021%,
70 parts by weight and 2 particle diameters of 20-200μ.

含水率019%のシ了ヌール酸20重相部、及び酸化マ
グネシウム(試桑−級品)10重量部を配合し均一に混
ぜた粉体組成物を作り、以下の評価試験を行なった。
A powder composition was prepared by uniformly mixing 20 parts of cylinuric acid with a water content of 0.19% and 10 parts by weight of magnesium oxide (trial grade), and the following evaluation tests were conducted.

評価試験 (Δ)水素イオン濃度の評ini ; 配合物中のTC(EAの有姿が50ツになる量をとり、
これにt)H7,32,Mアルカリ度(メチルオレンジ
を指示薬とし1強酸により 9− 簡定し水中に含捷nる炭酸塩等の総量を炭酸カルシウム
に換算した値)32m9/lの水道水1tに加え1時間
攪拌後、その水溶液を。
Evaluation test (Δ) Evaluation of hydrogen ion concentration; Take the amount that makes the presence of TC (EA) in the formulation 50,
Add to this t) H7,32,M alkalinity (value calculated by converting the total amount of carbonates, etc. contained in water into calcium carbonate by using methyl orange as an indicator and a strong acid) 32 m9/l of tap water After adding 1 t of water and stirring for 1 hour, the aqueous solution was added.

65℃で1週間放置し、残留塩素の大半が分解した後に
OHメータでpH’(r測定した。
After being left at 65° C. for one week and most of the residual chlorine decomposed, pH' (r) was measured using an OH meter.

結果を表1に示す。The results are shown in Table 1.

(B)保存安定性の評価; 内容積500mI!、の三つロガラス製容器内に配合粉
末202ケ入れ第10をゴム栓により封入し、第20及
び第30に弁封ガラス栓を取り付け、閉じた状態とし、
35℃の恒温槽に20日間静置保存した。その後、第2
0に乾燥窒素ガスの導管を連結し、第30に100ゴの
1%オル) l−IJレジン浴液に通ずる導管を連結し
、上記保存期間終了後2両弁を開き第20から乾燥窒素
ガスで上記容器内に発生し蓄積した分解ガスを、オルト
トリジン溶液に吸収させ、該浴液の着色度を波長440
 nmの黄色光の吸光度全分光々変針により測定し分解
ガス(塩素、塩化窒素)の発生量を求め 10− た。結果を表1に示す。
(B) Evaluation of storage stability; Internal volume 500mI! A 10th container containing 202 containers of mixed powder is sealed with a rubber stopper in a three-way glass container, and valve-sealing glass stoppers are attached to the 20th and 30th containers to close the container.
It was stored stationary in a constant temperature bath at 35°C for 20 days. Then the second
Connect the conduit for dry nitrogen gas to No. 0, and connect the conduit leading to the 100g (1% ol) l-IJ resin bath solution to No. The decomposed gas generated and accumulated in the container is absorbed into the orthotolidine solution, and the degree of coloring of the bath liquid is adjusted to a wavelength of 440.
The amount of generated decomposition gases (chlorine, nitrogen chloride) was determined by measuring the absorbance of yellow light at 10 nm using a full spectrophotometer. The results are shown in Table 1.

(C)湿潤安定性の評価; 内容積5Qa7の共栓付三角フラスコに1合粉末101
を入nる。その抜水1ornI!を、末の表面に注ぎ、
密栓し、65℃の恒温槽1に15分間静置保存し、その
後に開栓し、:解で生成したガスを感応試験により判定
し1結果を表1に示す。
(C) Evaluation of wet stability; 101 powders were added to an Erlenmeyer flask with a stopper and an internal volume of 5Qa7.
Enter. The water is drained 1ornI! Pour it on the surface of the end,
The container was sealed tightly and stored in a constant temperature bath 1 at 65° C. for 15 minutes, then opened, and the gas produced in the solution was determined by a sensitivity test. The results are shown in Table 1.

実施例2〜5及び比較例1〜9 表IJ示す組成で実施例1と同様の方法で−合し、粉末
の配合物を作り、実施例1と同様。
Examples 2 to 5 and Comparative Examples 1 to 9 The compositions shown in Table IJ were combined in the same manner as in Example 1 to form powder formulations and as in Example 1.

評価試験を行なった。An evaluation test was conducted.

又、粉末の配合物を錠剤にして評価も行な・た。錠剤化
に、30鎮fまたは25mmfの金tに粉末全入fL、
ロータリー打錠機により、圧佑圧力約400縁/crl
Vcより連続打錠成型するフ法によった。この様にして
径30 ya i 、厚み17M1重さ202又は径2
5顛f、厚み12跋9重さjOpの円筒状の錠剤を作っ
た。
We also evaluated the powdered formulation in tablet form. For tabletting, add powder to 30 mm f or 25 mm f,
Rotary tablet press produces approximately 400 cr/crl pressure.
A continuous tablet compression method was used from Vc. In this way, diameter 30 ya i, thickness 17M1 weight 202 or diameter 2
A cylindrical tablet with a length of 5 mm, a thickness of 12 mm, and a weight of 9 mm was made.

同、202の錠剤は保存安定性の評価jCj D Sの
錠剤は湿潤安定性の評価に用いた。
Tablet No. 202 was used for evaluation of storage stability. Tablet No. 202 was used for evaluation of wet stability.

表−1 j己 分 有 士 1己 髪 イ 1)OA;  シアヌール酸 2)◎ ; 開栓後、極めて弱い刺激臭またはほとんど
感じられ々い。
Table 1: 1) OA; Cyanuric acid 2) ◎; After opening the bottle, the odor is extremely weak or barely noticeable.

O; 開栓後1弱い刺激臭があり。O; There was a slight pungent odor after opening the bottle.

L ; 開栓後1強い刺激臭があり。L; There was a strong pungent odor after opening the bottle.

△ ; フラスコ内に黄色にならないが。△ ; There is no yellow color inside the flask.

閉栓後者しい刺激臭があり。There is a pungent odor similar to that of a closed bottle.

× ; 保存中に2分解ガスの発生が著しく、フラスコ
内が黄色になる。
×; The inside of the flask turns yellow due to significant generation of 2 decomposition gas during storage.

表−1に示す様に、TOOA、シアヌール酸。As shown in Table 1, TOOA, cyanuric acid.

酸化マグネシウムまたは水酸化マグネシウムの3成分系
でU、  pHの低下も小さく、即ち水素イオン濃度の
上昇が小さいし、粉体1錠剤ともに安定性が高い。TO
OAのみでは安定性は高いが、pHの低下が認められる
。また、ToOAにシアヌール酸のみを配合した場合も
、T。
With the three-component system of magnesium oxide or magnesium hydroxide, the decrease in U and pH is small, that is, the increase in hydrogen ion concentration is small, and the stability of each powder tablet is high. T.O.
Although stability is high with OA alone, a decrease in pH is observed. Furthermore, when only cyanuric acid is added to ToOA, T.

OAのみと同様の傾向である。The trend is similar to that of OA only.

一方、TOOAにアルカリ性物質(Na、 co、 )
 ’jz単独で配合する場合はp)Iの低下は抑えられ
るが、保存安定性、湿潤安定性は極端に低下し。
On the other hand, TOOA contains alkaline substances (Na, co, )
When 'jz is blended alone, the decrease in p)I can be suppressed, but the storage stability and wet stability are extremely reduced.

保存中水にぬrした場合々とでは危険である。It is dangerous if it gets wet with water during storage.

更にT OOA、シアヌール酸、酸化マグネシウム着た
に水酸化マグネシウムの6成分の配合においても、シア
ヌール酸が極端に少々い場合。
Furthermore, even in a combination of six ingredients: TOOA, cyanuric acid, magnesium oxide, and magnesium hydroxide, cyanuric acid is extremely low.

及び水酸化マグネシウムが多すき゛るといずれの場合も
安定性が低下する。
If the amount of magnesium hydroxide is too large, the stability will decrease in either case.

実施例6〜1o及び比較例1o〜16 表−2に示す組成で、実施例1と同様に均一に粉末を配
合し、また2錠剤にして評価をした。
Examples 6 to 1o and Comparative Examples 1o to 16 With the compositions shown in Table 2, powders were uniformly blended in the same manner as in Example 1, and two tablets were made for evaluation.

結果を表−2に示す。同、使用したシアヌール酸のマグ
ネシウム、カルシウム及びナトリウム塩は以下の様にし
て得た。
The results are shown in Table-2. Similarly, the magnesium, calcium and sodium salts of cyanuric acid used were obtained as follows.

シアヌール酸のマグネシウム塩; 粒子径2o〜200μ、含水率0,19%のイソシアヌ
ール酸1モル、水酸化マグネシウム粉末(試薬一級品)
1.5モルを水2tに加えスラリー水系で反応させ、脱
水乾燥して得た。
Magnesium salt of cyanuric acid; 1 mol of isocyanuric acid, particle size 2o~200μ, water content 0.19%, magnesium hydroxide powder (first grade reagent)
1.5 mol was added to 2 tons of water, reacted in an aqueous slurry system, and dehydrated and dried.

遊離水分15%(結晶水8%) 粒子径40〜150 
μ シアヌール酸のカルシウム塩; 」二記の水酸化マグネシウムを水酸化カルシウムに変え
て同様に反応させ、脱水乾燥して得た。
Free moisture 15% (crystal water 8%) Particle size 40-150
μ Calcium salt of cyanuric acid; 2. Magnesium hydroxide was replaced with calcium hydroxide, the reaction was carried out in the same manner, and the product was dehydrated and dried.

遊離水分1.2%(結晶水14%) 粒子径40〜15
0 μ シアヌール酸のナトリウム塩; 上記のイソシアヌール酸1モル、水酸化ナトリウム3モ
ルを水6tに加え均一水系で反応させ、冷却晶析し、脱
水乾燥して得た。
Free moisture 1.2% (crystalline water 14%) Particle size 40-15
0 μ Sodium salt of cyanuric acid: 1 mole of the above isocyanuric acid and 3 moles of sodium hydroxide were added to 6 tons of water, reacted in a homogeneous aqueous system, crystallized by cooling, and obtained by dehydrating and drying.

遊離水分1.5% 粒子径20〜150μ表 −2 1) (!A−Mg+シ了ヌール酸のマグネシウム塩2
) (’!A−Oa ;シアヌール酸のカルシウム塩3
) 0A−Na ;シアヌール酸のソーダ塩 15− 表−2にポス様に’l” COA、シアヌール酸のマグ
ネシウム塩またにシアヌール酸のカルシウム塩を用いた
場合、  pF(低下も極めて少く、保存安定性が優れ
ている事が判る。比較例に示す様にTOOAKシアヌー
ル酸のソーダ塩を配合すると、 pH低下を抑制する効
果はあるものの安定性が低下する事が判る。また、シア
ヌール酸のマグネシウム塩またはシアヌール酸のカルシ
ウム塩においても極端に少ない配合では安定性は良いが
、pH低下を抑制する事はでき々い。
Free moisture 1.5% Particle size 20-150μ Table -2 1) (!A-Mg + Magnesium salt of cylindrical acid 2
) ('!A-Oa ; Calcium salt of cyanuric acid 3
) 0A-Na; Sodium salt of cyanuric acid 15- Table 2 shows 'l' as shown in Pos. When COA, magnesium salt of cyanuric acid, or calcium salt of cyanuric acid is used, As shown in the comparative example, when the sodium salt of TOOAK cyanuric acid is blended, although it has the effect of suppressing the pH drop, it is found that the stability decreases. Alternatively, even if the calcium salt of cyanuric acid is used in an extremely small amount, the stability is good, but it is not possible to suppress the pH drop.

また逆に過剰の配合ではTo(’!Aの安定性を低下さ
せている。
On the other hand, excessive blending reduces the stability of To('!A).

特許出願人 日産化学工業株式会社  16−Patent applicant: Nissan Chemical Industries, Ltd. 16-

Claims (1)

【特許請求の範囲】 1、トリクロロインシアヌール酸100重量部に対して
次のA)又はB) A) イソシアヌール酸5〜100mt量部と酸化マグ
ネシウムまたは水酸化マグネシウム5〜80重量部 B)シアヌール酸のマグネシウム塩またはカルシウム塩
5〜100重量部 を配合する事を特徴とする殺菌消毒剤組成物。
[Scope of Claims] 1. The following A) or B) based on 100 parts by weight of trichloroin cyanuric acid A) 5 to 100 mt parts of isocyanuric acid and 5 to 80 parts by weight of magnesium oxide or magnesium hydroxide B) Cyanuric acid A sterilizing disinfectant composition comprising 5 to 100 parts by weight of a magnesium salt or a calcium salt of an acid.
JP17891982A 1982-10-12 1982-10-12 Disinfectant composition Granted JPS5967208A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP17891982A JPS5967208A (en) 1982-10-12 1982-10-12 Disinfectant composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP17891982A JPS5967208A (en) 1982-10-12 1982-10-12 Disinfectant composition

Publications (2)

Publication Number Publication Date
JPS5967208A true JPS5967208A (en) 1984-04-16
JPS6141883B2 JPS6141883B2 (en) 1986-09-18

Family

ID=16056938

Family Applications (1)

Application Number Title Priority Date Filing Date
JP17891982A Granted JPS5967208A (en) 1982-10-12 1982-10-12 Disinfectant composition

Country Status (1)

Country Link
JP (1) JPS5967208A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4855296A (en) * 1988-09-12 1989-08-08 Betz Laboratories, Inc. Biocidal compositions and use thereof
JPH03204802A (en) * 1989-10-06 1991-09-06 Shikoku Chem Corp Macrobiotic agent for cut flower and method for treating cut flower
US5230903A (en) * 1987-11-18 1993-07-27 Nissan Chemical Industries, Ltd. Chloroisocyanurate composition

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5230903A (en) * 1987-11-18 1993-07-27 Nissan Chemical Industries, Ltd. Chloroisocyanurate composition
US4855296A (en) * 1988-09-12 1989-08-08 Betz Laboratories, Inc. Biocidal compositions and use thereof
JPH03204802A (en) * 1989-10-06 1991-09-06 Shikoku Chem Corp Macrobiotic agent for cut flower and method for treating cut flower

Also Published As

Publication number Publication date
JPS6141883B2 (en) 1986-09-18

Similar Documents

Publication Publication Date Title
US5021186A (en) Chloroisocyanuric acid composition having storage stability
US7695639B2 (en) Calcium hypochlorite compositions
US8679548B2 (en) Active bromine containing biocidal compositions and their preparation
US8944048B2 (en) Apparatus and methods of providing diatomic oxygen (O2) using ferrate(VI)-containing compositions
AU781655B2 (en) Stable, high available halogen 1,3,5-triazine-2,4,6-trione compositions having rapid dissolution rates
CA2042430A1 (en) Water treatment blend in solid form
JPH11505245A (en) Chloroisocyanuric acid composition with reduced gas generation
JPS5967208A (en) Disinfectant composition
US5230903A (en) Chloroisocyanurate composition
US3346446A (en) Hypoiodous acid generating compositions
JP2643199B2 (en) Chloroisocyanurate composition
JP2606266B2 (en) Chlorinated isocyanuric acid composition with storage stability
US3265578A (en) Stabilized solid composition soluble in water to form hypoiodus acid
JP2003160417A (en) Chlorinated isocyanuric acid composition having excellent storage stability
CZ43398A3 (en) Water treatment process
MXPA00009525A (en) Stable, high available halogen 1,3,5-triazine-2,4,6-trione compositions having rapid dissolution rates
MXPA97008754A (en) Compositions of chloroisocianuric acid which has reduced reduction of